Untreated MDD: Brain Changes, Cognitive Burden, and Comorbid Anxiety

Researchers noted that anxiety may accelerate or exacerbate neurodegenerative patterns seen in chronic depression

A panel of psychiatrists reviewed current evidence on September 28, 2026, discussing how untreated major depressive disorder may lead to measurable brain changes and increased cognitive burden, particularly when anxiety is present. The discussion took place during a virtual symposium focused on early intervention strategies. Experts emphasized that while imaging findings show associations, they do not prove causation. The panel examined neuroimaging data revealing structural and functional alterations in brain regions linked to mood regulation and executive function in individuals with prolonged untreated depression. These changes were often more pronounced in patients also experiencing comorbid anxiety disorders, which can intensify cognitive symptoms like difficulty concentrating and memory lapses.

Researchers noted that anxiety may accelerate or exacerbate neurodegenerative patterns seen in chronic depression, complicating both diagnosis and treatment planning. How Strong Is the Evidence for Early Treatment? The psychiatrists debated whether associative imaging results justify initiating treatment earlier in the course of depression, especially for skeptical clinicians who demand causal proof. Dr. Gus Alva argued that waiting for definitive causation could mean missing a critical window for intervention, given the progressive nature of brain changes observed. Dr. Anita Clayton added that cognitive decline and functional impairment often emerge before full syndromal depression is recognized, suggesting a need for vigilance in high-risk groups. What Role Does Anxiety Play in Shaping Outcomes? Comorbid anxiety was highlighted as a key modifier that worsens prognosis and complicates treatment response in MDD. Dr.

Charles Debattista explained that anxiety symptoms frequently precede or co-occur with depressive episodes

Charles Debattista explained that anxiety symptoms frequently precede or co-occur with depressive episodes, creating a more severe clinical picture marked by greater emotional dysregulation and reduced treatment adherence. The panel noted that standard antidepressants may be less effective when anxiety is dominant, requiring tailored approaches such as combining psychotherapy with pharmacotherapy or using agents specifically targeting both conditions. Frequently Asked Questions Can brain changes from untreated depression be reversed with treatment? Some studies indicate partial recovery of brain volume and connectivity with timely intervention, though the extent of reversibility depends on duration and severity of illness, as well as individual factors like age and genetics. Why does anxiety make depression harder to treat? Anxiety increases physiological arousal and negative thought patterns, which can interfere with the effectiveness of standard antidepressants and require longer treatment durations or combination therapies to achieve remission.

Is cognitive burden in depression always linked to structural brain changes? Not necessarily; cognitive symptoms can also stem from neurotransmitter imbalances, sleep disruption, or psychological factors, though imaging often shows correlations in chronic or severe cases.